Frigid
5 papers2 directions
Frigid is a research venue that was active between 2022 and 2024, focusing on molecular biology, regenerative medicine, and the physiological impacts of cold environments. The venue is characterized by its focus on paracrine senescence, the decline of tissue regeneration, and the maturity gap in human stem cell models. A significant portion of its corpus explores the restoration of autophagic flux to clear pathological protein aggregates and the signaling pathways involved in cellular aging and recovery.
The research presented at Frigid includes investigations into myocardial ischemia-reperfusion injury and the therapeutic potential of Growth Differentiation Factor 11 (GDF11) in promoting autophagy and macrophage polarization. The venue also features studies on the role of the cold-sensitive channel TRPM8 in controlling low temperature-induced bone metabolic imbalance, alongside broader research into osteoporosis in cold areas. These publications examine how specific molecular regulators, such as long non-coding RNAs and the Notch1 signaling pathway, influence cardiovascular and skeletal health.
Prolific contributors to the venue include researchers such as Dongping Liu, Han Sun, Lei Jiao, and Ping Zhou. By hosting work on endothelial progenitor cell aging and the molecular mechanisms of tissue repair, Frigid serves as a specialized platform for disseminating findings in the fields of senescence and environmental physiology. The venue’s corpus of five papers contributes to the scientific understanding of complex biological responses to both internal aging processes and external environmental stressors.
Papers by Year
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 1 |
Top Research Directions
Research directions most represented by papers from this venue.
| The Cellular Maturation Gap in Stem Cell Models | 1 |
| Enhancing Stem Cell Survival in Hostile Tissue Microenvironments | 1 |